Obesity is a chronic, multifactorial disease influenced by biology.
Gelesis develops GI & Metabolic based biomimetic therapies designed to support physiology and long-term health outcomes.
By working locally in the GI tract, our oral materials-based superabsorbent hydrogel aims to influence satiety-related signals and support metabolic health-grounded in measurable mechanisms and clinical validation.
The Gelesis OHS platform is a proprietary superabsorbent hydrogel technology designed to work locally in the GI tract. Built from naturally derived building blocks, it is engineered to support GI physiology relevant to chronic disease.
Introducing Plenity
Plenity® is indicated to aid in weight management in adults who are overweight or obese and have a body mass index (BMI) of 25 to 40 kg/m² when combined with diet and exercise.
How it works
In clinical trials, Plenity demonstraded statistically significative weight reduction and positively impacted other metabolic parameters